Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Gastric Ulcers Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The gastric ulcers market size has seen substantial growth over recent years. It is projected to increase from $4.53 billion in 2025 to $4.78 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.5%. This historical expansion can be linked to the widespread occurrence of H. pylori infection, the extensive consumption of antacids, the availability of antibiotics, gastrointestinal treatments provided in hospitals, and the wider acceptance of endoscopic diagnosis methods.
The gastric ulcers market size is anticipated to show steady growth over the next few years. It is projected to expand to $5.78 billion in 2030, achieving a compound annual growth rate (CAGR) of 4.9%. The observed growth during the forecast period is attributable to the advancement of sophisticated acid-suppression drugs, the demand for sustained ulcer management, an increase in outpatient care, enhancements in diagnostic technologies, and a rise in lifestyle-related disorders. Primary trends for the forecast period encompass an increased adoption of proton pump inhibitors, a growing emphasis on Helicobacter pylori eradication, an expansion in combination drug therapies, the development of non-invasive diagnostic methods, and heightened awareness of gastrointestinal disorders.
Get A Free Sample Report With In-Depth Market Insights:
Gastric Ulcers Market Growth Momentum: What Factors Are Shaping Demand?
The increasing geriatric population is expected to drive the growth of the gastric ulcers market in the future. This demographic consists of individuals typically 65 years and older, who have particular health considerations associated with aging. The rise in the elderly population can be attributed to advances in healthcare, resulting in increased life expectancy, and declining birth rates across many global regions. Gastric ulcers are prevalent among older adults due to a greater use of NSAIDs and diminished mucosal protection, which often leads to a higher risk of complications. For example, in January 2024, the Population Reference Bureau (PRB), a US non-profit organization, stated that the American population aged 65 and above is projected to grow from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Additionally, this age group’s share of the total population is anticipated to increase from 17% to 23%. This change signifies a substantial aging trend in the U.S. population, highlighting the growing importance of addressing the requirements of older adults across various sectors. Hence, the expanding geriatric population is fueling the growth of the gastric ulcers market.
Gastric Ulcers Market Breakdown By Product Type And Application
The gastric ulcers market covered in this report is segmented –
1) By Drug Class: Proton Pump Inhibitors (PPI), H2 Antagonists, Antacids, Antibiotics, Cytoprotective Agents, Other Drug Classes
2) By Diagnosis: Stool Test, Endoscopy, Imaging Tests, Computed Tomography (CT) Scan, X-ray, Blood Tests, Other Diagnosis
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End Users
Subsegments:
1) By Proton Pump Inhibitors (PPI): Omeprazole, Lansoprazole, Pantoprazole, Esomeprazole, Rabeprazole
2) By H2 Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine
3) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide, Sodium Bicarbonate
4) By Antibiotics: Amoxicillin, Clarithromycin, Metronidazole, Tetracycline
5) By Cytoprotective Agents: Sucralfate, Misoprostol, Bismuth Subsalicylate
6) By Other Drug Classes: Prostaglandin Analogues, Prokinetic Agents, Herbal And Alternative Medications, Combination Therapies
Gastric Ulcers Market Trends: What’s Defining The Industry’s Next Phase?
Leading companies in the gastric ulcer market are concentrating on developing novel products, such as advanced formulations of drugs, to elevate treatment efficacy and lessen side effects. New formulation drugs refer to medicines created with innovative combinations of active ingredients, delivery methods, or dosage forms to enhance their effectiveness, safety, and patient adherence. For instance, in June 2024, Akums Drugs and Pharmaceuticals Ltd., an India-based pharmaceutical preparation manufacturing company, launched Rabeprazole + Levosulpiride SR Capsules, aiming to provide improved relief for conditions like gastro-oesophageal reflux disease (GERD) and other gastrointestinal tract (GIT) disorders. These products combine a proton pump inhibitor and a prokinetic agent, effectively managing gastrointestinal disorders such as gastroesophageal reflux disease (GERD) and gastric ulcers. This particular formulation not only reduces gastric acid secretion but also boosts gastric motility, offering comprehensive relief from symptoms like heartburn and indigestion.
Gastric Ulcers Market Company Landscape And Competitive Strategy
Major companies operating in the gastric ulcers market are Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC
View The Full Gastric Ulcers Market Report:
Gastric Ulcers Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the gastric ulcers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
